应用 |
An immunosuppresive inhibitor of FRAP (mTOR). |
产品介绍 |
Everolimus (RAD001)是一种mTOR抑制剂,作用于FKBP12,IC50为1.6-2.4 nM。 |
备注 |
Everolimus (RAD001) is an mTOR inhibitor of FKBP12 with IC50 of 1.6-2.4 nM. |
生化机理 |
Everolimus is a macrolide derived from rapamycin with immunosuppressant properties shown to inhibit cell proliferation induced by growth factors. Macrolides belong to a group of antibiotics that bind to the 50S ribosomal subunit and inhibit protein synthesis. Studies indicate that everolimus is a mTOR (FRAP) inhibitor that displays high affinity toward the intracellular receptor FKBP12. Additionally, the Everolimus-FKBP12 complex decreases the activity of the S6K1 and 4EBP by binding to FRAP |
别名 |
依维莫司;RAD001; SDZ-RAD; Certican; Zortress; Afinitor;RAD 001;40-O-(2-Hydroxyethyl)rapamycin; 42-O-(2-Hydroxy)ethyl Rapamycin |